What we offer you

Who we work with


  • Pinnacle Technology Group plc
  • Minds + Machines Group

Life Sciences

  • Summit Corp. PLC
  • e-Therapeutics PLC
  • Verona Pharma Plc

Support Services

  • Waterman Group PLC
  • Superglass Holdings PLC
  • T. Clarke PLC

Investment Funds

  • Infrastructure India PLC
  • Ottoman Fund Ltd
  • Tetragon Financial Group Ltd.
See all sectors


June 2, 2015

Oxford Pharmascience Group plc, the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, has announced that it has conditionally raised £20 million via a placing of up to 200,000,000 new Ordinary Shares with both new and existing shareholders (the “Placing”) at a price of 10 pence per share. The new Ordinary Shares will represent up to 16.6% of the Company’s issued ordinary share capital immediately following Admission.


May 1, 2015

Latest report

Q1 Update – April 2015

Published on May 1, 2015

Download report